Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  InterMune Inc    

INTERMUNE INC

 SummaryNewsCompany 
Company
More about the company
Latest news on INTERMUNE INC
2014INTERMUNE : Announces Effective Date of Make Whole Fundamental Change and Offer ..
PU
2014INTERMUNE : Reports Memorandum of Understanding in Connection with Consolidated ..
PR
2014Roche's $8 billion InterMune buy not a signal for more big deals
RE
2014INTERMUNE : Announces Anticipated Fundamental Change for 5.00% Convertible Senio..
PR
2014Roche rules out mega deals, open to smaller ones - paper
RE
2014InterMune drug may offer big upside to Roche if aimed at liver
RE
2014INTERMUNE : Stockholders Encouraged to Contact Securities Law Firm about Takeove..
PR
2014INTERMUNE : SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincen..
BU
2014INTERMUNE : INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating the Board of D..
BU
2014INTERMUNE : INVESTOR ALERT – InterMune, Inc.: The Law Offices of Vincent W..
BU
2014INTERMUNE : SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of..
BU
2014INTERMUNE : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Int..
PR
2014INTERMUNE : Ryan & Maniskas, LLP : Announces Investigation of InterMune, Inc.
PR
2014INTERMUNE : INVESTOR ALERT: Faruqi & Faruqi, LLP Announces the Investigation of ..
PR
2014INTERMUNE : SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger..
PR
More news
News in other languages on INTERMUNE INC
2014WALL STREET STOCK EXCHANGE : Wall Street finit dans le vert, le S&P passe un cap
2014Wall Street ouvre en hausse sur un nouveau record du S&P
2014USA-Les valeurs à suivre à Wall Street
2014Roche achète l'américain InterMune pour 8,3 milliards de dollars
2014Roche va racheter l'américain InterMune pour $8,3 mds
More news
Analyst Recommendations on INTERMUNE INC
More recommendations
Sector news : Biotechnology & Medical Research - NEC
11/14BEIGENE : FDA Gives Accelerated Approval to BeiGene's Brukinsa
DJ
11/14Walt Disney soars while Cisco disappoints
11/14THERMO FISHER SCIENTIFIC : Qiagen Shares Surge on Report Thermo Fisher Mulling D..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
11/07GILEAD SCIENCES : U.S. Sues HIV Drugmaker Gilead Alleging It Infringed on PrEP P..
DJ
More sector news : Biotechnology & Medical Research - NEC
Managers
NameTitle
Edward Harrington Chief Executive & Financial Officer
Marianne T. Armstrong Chief Medical Affairs & Regulatory Officer
Nicholas Simon Director
Jay P. Shepard Director
Carla Fiankan Vice President-Regulatory
Sector and Competitors
1st jan.Capitalization (M$)
INTERMUNE INC0
IQVIA HOLDINGS INC.26.11%28 427
LONZA GROUP33.49%25 529
CELLTRION, INC.--.--%20 414
SEATTLE GENETICS, INC.102.52%19 667
INCYTE CORPORATION34.91%18 675